*If You Own GPRO, IBIO, IVR Then Click Here to Join Our Community Of Traders
The Market Signal was created as a platform to help investors, if you own (NASDAQ:GPRO), (NYSE:IBIO) or (NYSE:IVR) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.
https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)
GoPro Q2 2020 Financial Results
https://themarketsignal.com/Free-Report/GPRO
(Click link above or copy, paste and hit enter in your browser for your report)
GoPro Inc (NASDAQ:GPRO) The company has a market capitalization of $754.48 billion and is one of the most popular stocks on Robinhood
| Q2 2020 | Q1 2020 | Q2 2019 | |
| Revenue | $134 million | $119 million | |
| GAAP gross margin | 30.3% | 34.9% | |
| Net Loss | $51 million | ||
| Operating Expenses | $86 million | ||
| EBITDA | -$22 million | $14 million | |
| Cash and investments | $80 million | $110.26 million |
GoPro sold a total of 750,000 cameras in Q2 2020. The company reported a 25% reduction in inventory and 45% since Q4 2019. Sales from GoPro.com, the company's online sales platform accounted for 445 of the total revenue in Q2 2020. This is a big increase from Q2 when online sale accounted for just less than 10% of the total sales.
At the end of the quarter, GoPro's Plus subscription service added 372,000 more paid subscribers representing a 5% increase from the previous quarter and 57% year-over-year. Cameras that retail above $300 accounted for 95% of Q2 2020 revenue, which is an indication of customer preference for the company's premium products. The company reported an 11% increase in street ASPs to $300 compared to last year.
Ibio 's proprietary vaccine candidates produces immune response against SARS-CoV-2 virus
https://themarketsignal.com/Free-Report/IBIO
(Click link above or copy, paste and hit enter in your browser for your report)
Ibio Inc (NYSE:IBIO). The company has a market capitalization of $517.05 million and is one of the most popular stocks on Robinhood
iBio, Inc. has issued an update on SARS-CoV-2 virus, its proprietary vaccine candidates being tested for treatment of COVID-19. The company is investigating several adjuvants together with its proprietary lichenase carrier molecule ("LicKMTM") fused to a coronavirus subunit protein ("IBIO-201").
The company has conducted ten distinct preclinical study arms for the IBIO-201 antigen-adjuvant combinations. Among them are combinations delivered through intramuscular and intranasal routes, and datasets which are still under evaluation. IBIO-201 produced a positive response against SARS-CoV-2 for 21 days after immunization.
The positive response against SARS-CoV-2 was observed for another 21 days after immunization.
Mouse antisera from IBIO-201 immunized mice were tested and showed presence of antibodies that prevent SARS-CoV-2 from binding to human ACE2 in ex vivo assays. The company says it will conduct additional tests on IBIO-201 antisera to further evaluate the neutralizing titers in multiple assay formats. More tests will also be conducted to evaluate the safety and immune response of the product. The additional tests for both neutralizing titers in multiple assay formats. will be conducted in partnership with Texas A&M University System ("TAMUS") laboratories.
Invesco Mortgage Capital announces Q2 2020 Financial Results
https://themarketsignal.com/Free-Report/IVR
(Click link above or copy, paste and hit enter in your browser for your report)
Invesco Mortgage Capital Inc (NYSE:IVR). The company has a market capitalization of $542.74 million and is one of the most popular stocks on Robinhood.
| 2Q 2020 | 1Q 2020 | |
| Proceeds Of From Sale Of Securities | $6.9 billion | |
| Repurchase Agreement Borrowings | $6.3 billion | |
| Net Loss | $299.9 million | |
| Book value | $3.17 | $5.02 |
| Management Fees | $9.8 million | $11.0 million |
Invesco Mortgage Capital reported $299.9 million in Net Loss attributable to common stockholders in the Q2 2020. The loss is mainly due to a net loss on investment of $306.4 million plus expenses amounting to $13.9 million which were partially paid using net interest rate of $29.7million.
Please email or contact us for any edits or errors relating to this stock market news.
If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.
We will get back to you within 24 hours.
COMTEX_369227251/2700/2020-08-11T09:10:42
Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.
